90 likes | 183 Views
Scaling Up A ccess and Rational D rug U se. Anthony D. So, MD, MPA Program on Global Health and Technology Access Sanford School of Public Policy Duke University ICIUM November 2011. Hurdles to Drug Access. R&D Pipeline. Therapeutic. Marketplace. Financial. Structural. Delivery
E N D
Scaling Up Access and Rational Drug Use Anthony D. So, MD, MPA Program on Global Health and Technology Access Sanford School of Public Policy Duke University ICIUM November 2011
Hurdles to Drug Access R&D Pipeline Therapeutic Marketplace Financial Structural Delivery System Source: Health Action International-Peru
Where in the value chain to intervene? Community management
Global Drug FacilityGreen Light Committee Gupta et al. “Responding to Market Failures in Tuberculosis Control.” Science (2011) 293 (5532): 1049-1051.
Affordable Medicines Facility for Malaria AMFm Co-Payment Fund US$216 million Financed by UNITAID, Gates Foundation, DFID Supporting Interventions Up to US$ 126.7 million Financed by Global Fund
AMFm: Issues of Supply and Demand Supply Demand No. of treatments approved for co-payment Multinational corporations supply roughly one-third of co-pay approved treatments* Source: AMFm, 2001. *These figures do not count co-payments through AMFm's Voluntary Pooled Procurement mechanism or ACTspurchased through the President's Malaria Initiative. Source: OlusojiAdeyi, Affordable Medicines Facility-malaria (AMFm): Achievements to date, UNITAID Consultative Forum, October 4, 2011, Geneva.
Source: Rutta, Edmund, et al. Increasing Access to Subsidized Artemisinin-based Combination Therapy through Accredited Drug Dispensing Outlets in Tanzania. Health Research Policy and Systems 2011; 9:22